Cervical cancer screening in the early post vaccine era.
The Pap test is the foundation of cervical cancer screening in North America and most industrialized countries. It has been widely used in the United States since the 1950s. But are our current screening guidelines still justified? In this article, the author reviews the current recommendations for cervical cancer screening by the American Cancer Society (ACS) and the American College of Obstetricians and Gynecologists (ACOG) and the evidence supporting them, reviews the relative efficacy of liquid-based cytology versus the conventional Pap smear, and discusses the role of HPV DNA testing in primary screening.
Waxman
Alan G
AG
Department of Obstetrics and Gynecology, University of New Mexico School of Medicine, University of New Mexico, MSC10 5580, Albuquerque, NM 87131-0001, USA. awaxman@salud.unm.edu
D004279:DNA, Viral / Q000737:chemistry / Q000235:genetics; D005260:Female; D006801:Humans; D008403:Mass Screening / Q000379:methods*; D065006:Papanicolaou Test; D027383:Papillomaviridae / Q000302:isolation & purification; D030361:Papillomavirus Infections / Q000150:complications / Q000175:diagnosis* / Q000517:prevention & control; D053918:Papillomavirus Vaccines; D011230:Precancerous Conditions / Q000175:diagnosis / Q000517:prevention & control; D014412:Tumor Virus Infections / Q000150:complications / Q000175:diagnosis* / Q000517:prevention & control; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis* / Q000209:etiology / Q000517:prevention & control; D014626:Vaginal Smears / Q000379:methods*
D004279:DNA, Viral; D053918:Papillomavirus Vaccines